Lipsyc-Sharf, M., Hurvitz, S. A. (2026). Current Management of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in a Changing Landscape. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-00672